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ABSTRACT 
 
PURPOSE.  This study examined the relationship between high myopia and three myopia candidate 
genes, namely matrix metalloproteinase 2 (MMP2) and tissue inhibitor of metalloproteinase 2 and 3 
(TIMP2 and TIMP3), involved in scleral remodeling. 
 
METHODS. The study recruited unrelated adult Han Chinese who were high myopes (spherical 
equivalent ≤-6.0D for both eyes; cases) and emmetropes (within ±1.0D for both eyes; controls). 
Sample Set 1 had 300 cases and 300 controls while Sample Set 2 had 356 cases and 354 controls. 
Forty-nine tag single nucleotide polymorphisms (SNPs) were selected from these candidate genes. 
The first stage was an initial screen of 6 case pools and 6 control pools constructed from Sample Set 1, 
each pool consisting of 50 distinct subjects of the same affection status. In the second stage, 
“positive” SNPs from the first stage were confirmed by genotyping individual samples forming the 
DNA pools. In the third stage, positive SNPs from stage 2 were replicated with Sample Set 2 
genotyped individually. 
 
RESULTS.  Of the 49 SNPs screened by DNA pooling, 3 passed the lenient threshold of P <0.10 
(nested ANOVA) and were followed up by individual genotyping. Of the 3 SNPs genotyped, two 
TIMP3 SNPs were found significantly associated with high myopia by single-marker or haplotype 
analysis. However, the initial positive results could not be replicated by Sample Set 2. 
 
CONCLUSIONS. MMP2, TIPM2 and TIMP3 genes were not associated with high myopia in 
Chinese and hence were unlikely to play a major role in the genetic susceptibility to high myopia. 
 
(250 words) 
 
 3 
INTRODUCTION 
In myopia, the images of distant objects are focused in front of, rather than on, the retina under 
relaxed accommodation. Myopia is the commonest eye anomaly in the world and imposes a huge 
impact on the public health care system and the economy.1 In particular, subjects with high myopia, 
usually defined as ≤-6.0 diopters (D), are more prone to ocular degenerative changes such as 
glaucoma and retinal detachment. Myopia is much more frequent in Orientals (60-80%) than in 
Caucasians (10-25%) although its prevalence varies with time, the age of the subjects, and the ethnic 
origin of the population concerned.2 In Hong Kong, the prevalence is highest (70%) for age 19-39, 
and then drops after age 40.3 
 
 Both environmental and genetic factors contribute to myopia although the exact cause of 
myopia remains to be determined.4-6 Environmental factors such as lifestyle, schooling, near-work and 
outdoor activities are known to contribute to differences in the prevalence of myopia. Estimates of 
heritability are high for refractive error and major ocular components, and shared genes between 
relative pairs could explain the strong correlation between refractive error and axial length.7-9 
 
 Myopia mainly results from elongated eyeball caused by accelerated postnatal eye growth, 
rather than changes in corneal or lens power.10 During myopia development, the sclera undergoes 
active remodeling, which involves matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) –  the enzymes involved in the degradation of extracellular matrix. 
Matrix metalloproteinase 2 (MMP2) is increased in the sclera of the myopic eye induced by form 
deprivation in chicks when compared to the control eye, and the increased expression has been 
consistently shown for both the protein11-14 and the mRNA transcript.14,15 Increased scleral MMP2 
expression in form-deprivation myopia has also been shown in tree shrew at both the protein16 and the 
mRNA level,17,18 and in guinea pig at the protein level.19 Increased MMP2 transcript level has also 
been found in human scleral fibroblasts mechanically stretched in an in vitro system,20 in lens-induced 
myopia in tree shrew,21 but not in lens-induced myopia in chick.22 On the other hand, there is less 
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extensive study of TIMP expression in induced myopia. TIMP2 expression is found to be reduced in 
form deprivation myopia in chick14 and in lens-induced myopia in guinea pig,19 but at comparable 
levels as the control eye in lens-induced myopia in both tree shrew21 and chick.22 Finally, TIMP3 
transcript level is found to be reduced in lens-induced myopia in tree shrew.21 These studies did not 
specifically examine any potential interaction among these three genes. 
 
 We used a case-control study approach23 to examine the relationship between high myopia in 
a Han Chinese population and the tag single nucleotide polymorphisms (SNPs) of three candidate 
genes. These three candidate genes were selected for this study because their involvement in scleral 
remodeling has been confirmed by extensive studies of animal myopia models, as has been 
summarized above. We performed the case-control study in three stages: (1) initial screen of DNA 
pools to identify putatively positive SNPs, (2) confirmation of “positive” SNPs by genotyping of 
individual DNA samples forming the original pools, and (3) replication of positive SNPs by an 
independent sample set (Fig. 1). The initial DNA pooling step served to reduce the cost and time 
involved in individual genotyping.23,24 DNA pools were created by mixing equal amounts of DNA 
from many individuals sharing the same disease status. Thus, “case pools” were constructed from 
subjects with high myopia (cases) and “control pools” from emmetropic subjects (controls) in this 
study. Moreover, we adopted an optimal experimental design in DNA pooling step by creating small 
DNA pools each constructed from 50 distinct individuals of the same disease status.25 
 
 
METHODS 
Subjects and DNA samples 
In DNA pooling-based initial study, 600 unrelated Southern Han Chinese subjects (Sample Set 1) 
were recruited: 300 cases of high myopes with spherical equivalent (SE) ≤−8.00D  in both eyes, and 
300 emmetropic controls with SE within ±1.0 D in both eyes. Positive SNPs from the DNA pooling-
based initial screen were confirmed by individual genotyping of the original Sample Set 1 and, if 
confirmed, replicated by testing a second sample set (Sample Set 2). Sample Set 2 consisted of 710 
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unrelated Han Chinese subjects with 356 cases and 354 controls. The same entry criteria were used 
for subject recruitment of both sample sets. This study was approved by the Human Subjects Ethics 
Subcommittee of the Hong Kong Polytechnic University, and adhered to the tenets of the Declaration 
of Helsinki. Signed, informed consents were obtained from all participants. All subjects were 
recruited from the Optometry Clinic of the Hong Kong Polytechnic University, and collection of 
blood samples and DNA extraction were performed as described previously.26 
 
Construction of DNA pools 
For the DNA pooling study, all DNA samples were accurately quantified by a PicoGreen method 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions and diluted to a final 
concentration of 5±0.3 ng/μl. Equal volumes of DNA solutions were mixed to create DNA pools. Six 
case pools and six control pools were constructed for Sample Set 1, each consisting of 50 distinct 
individuals of the same disease status. 
 
Selection of tag SNPs 
Three candidate genes were selected for study: MMP2, TIMP2 and TIMP3. Tagger implemented in 
Haploview (http://www.broadinstitute.org/haploview/haploview) was used to select tag SNPs with the 
following setting: pairwise tagging algorithm, r2≥0.8 and minor allele frequency (MAF) of more than 
0.1. The selection was based on the Han Chinese genotype data from the International HapMap 
Project database (release 23a, phase II; http://www.hapmap.org/) for these three loci and their 
flanking regions (3 kb upstream and 3 kb downstream of the genes). In total, 49 tag SNPs were 
selected from these 3 genes for analysis by the DNA pooling strategy (Table 1). 
 
Allele frequency estimation in DNA pools 
The same protocols were used for all 50 SNPs examined unless stated otherwise. Touchdown PCR 
was performed in a total volume of 15-μl reaction mixture containing 25 ng of genomic DNA 
template, 0.1 µM of each primer (Supplementary Table S1) and 1.5 mM MgCl2 , 0.2 mM of each 
dNTP and 0.2 U of HotStarTaq Plus DNA Polymerase (Qiagen, Hilden, Germany) in 1× PCR buffer 
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provided by the manufacturer. There were a few exceptions: 0.3 µM of each primer was used for 3 
SNPs (rs243845, rs11639960 and rs12600817) and 2.5 mM of MgCl2 for 2 SNPs (rs11639960 and 
rs12600817). Amplification was performed in a GeneAmp PCR system 9700 (Applied Biosystems, 
Foster City, CA). The touchdown thermocycling program included activation at 95ºC for 5 min, 
followed by 6 cycles of 95ºC for 30 seconds, 64°C (initial annealing temperature) for 45 seconds and 
decreased by 1ºC per cycle, and 72 ºC for 45 seconds, plus additional 38 cycles of 95ºC for 30 
seconds, 58 ºC (final target annealing temperature) for 45 seconds and 72ºC for 45 seconds; and final 
extension at 72ºC for 7 minutes. There were a few exceptions: the initial and final annealing 
temperatures were 62 ºC and 56 ºC for 4 SNPs (rs11643630, rs243845, rs11639960 and rs12600817). 
 
 PCR products were purified using shrimp alkaline phosphatase and exonuclease I. Primer 
extension (PE) reactions were performed in a 25-μl reaction volume containing 10 μl purified PCR 
products, 1.5 μM of the specific primer (Supplementary Table S1), 50 μM of each appropriate ddNTP 
and/or dNTP (Supplementary Table S1) and 1 unit of Therminator (New England Biolabs, Beverly, 
MA) in a 1× reaction buffer supplied by the manufacturer. Thermocycling was performed with an 
initial denaturation step at 96ºC for 1 minute, followed by 55 cycles of 96ºC for 10 seconds, 43ºC for 
15 seconds and 60ºC for 1 minute. 
 
 Denaturing high performance liquid chromatography (DHPLC) analysis was performed using 
the WAVE Nucleic Acid Fragment Analysis System (Transgenomic Inc, Omaha, NE). PE products 
were analyzed with a 6% linear gradient change of the working elution buffer over a 3-minute period 
and a different starting concentration of buffer B, dependent on the SNP concerned (Supplementary 
Table S1).27 Relative allele frequencies in DNA pools were estimated based on the intensity of 
primer-extended products by DHPLC. For each DNA pool, the analysis included a single PCR 
followed by a single PE reaction and a single DHPLC analysis. Each DNA pool was analyzed in 
triplicates (Fig. 2). In other words, there were 36 sets of readings for 6 case pools and 6 control pools 
(Sample Set 1) for each SNP. 
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Individual genotyping  
The positive findings (3 SNPs) in the DNA pooling-based initial study were confirmed by individual 
genotyping of the same sample set (Set 1) with MassArray iPLEX chemistry (Sequenom, San Diego, 
CA; Supplementary Table S2) according to the manufacturer’s instructions 
(http://www.sequenom.com/). These 3 SNPs were grouped together with SNPs of other on-going 
studies for genotyping using MassArray iPLEX method carried out by a local service provider 
(http://genome.hku.hk/portal/). The confirmed positive results were tested by a follow-up replication 
study on Sample Set 2. 
 
 For Sample Set 2, two SNPs of the TIMP3 gene (rs135029 and rs137485) were genotyped by 
unlabeled probe melting analysis.28 This method uses asymmetric PCR to generate single-stranded 
DNA (ssDNA) product, and an unlabeled probe that is 3’-blocked by a phosphate group to prevent 
probe extension. After PCR, the unlabeled probe and a saturating dsDNA dye are added to ssDNA 
target for high-resolution melting analysis. Asymmetric PCR reaction was performed in a 10-μL 
reaction mixture containing 10 ng of genomic DNA, 3.5 mM MgCl2, 0.1 μM forward primer (excess),  
0.01 μM reverse primer (limiting) (Supplementary Table S2), 0.2 mM of each dNTP, 1× PCR buffer 
and 0.2 U of HotStarTaq Plus DNA Polymerase (Qiagen). Amplification was performed in 96-well 
plates with a GeneAmp 9700 PCR system, including 1 cycle of initial denaturation for 5 minutes at 
95°C, 50 cycles of 30 seconds at 95°C, 50 seconds at 55°C for annealing, and 25 seconds at 72°C, 
plus 1 cycle of final extension for 5 minutes at 72°C. After PCR, a 10-μL reaction mixture containing 
8.4 μl PCR product, 0.5 μM unlabeled probe (International DNA Technologies, Coralville, IA) and 
2.5 mM SYTO 9 green fluorescent nucleic acid stain (Invitrogen) was prepared in 96-well white 
plates. Melting was performed in a LightCycler 480 instrument (Roche Diagnostics, Mannheim, 
Germany) with heating of samples to 95°C for 1 minute and then cooling to 50°C for 1 minute. The 
melting data were then collected between 50°C and 95°C with a heating rate of 0.11°C/s at 5 
acquisitions per °C, using the “melting curves” analysis mode. Samples were again cooled to 40°C for 
10 seconds. Melting curves were analyzed with LightCycler 480 Software (Version 1.5, Roche). 
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Statistical Analysis 
Ocular data were analyzed using the STATA package (version 8.2; StataCorp, College Station, Texas). 
High myopia was examined as a dichotomous trait. Subjects were classified as affected (cases) or 
unaffected (controls). In PE, unequal representation of the two alleles of a SNP can result from 
differential incorporation of ddNTPs, and was corrected with a correction factor (known as k 
correction factor)29 estimated based on the average of three independent replicate readings from a 
heterozygous sample. Relative allele frequencies of a given SNP were estimated from the heights (i.e. 
intensities) of the two peaks representing the two extension products in the DHPLC elution profile 
with correction by the k correction factor.29 The relative allele frequencies of a SNP were compared 
between the pools of the case group and the pools of the control group by nested analysis of variance 
(nested ANOVA; see online supplementary materials for explanation)30 carried out using the STATA 
package. SNPs with P value ≤0.10 were followed up by genotyping individual samples forming the 
DNA pools (Sample Set 1). A lenient threshold of P ≤0.10 was used in order not to exclude any 
potentially significant SNPs. 
 
 Genotype data of individual samples (Sample Set 1 or 2) were analyzed by the PLINK 
package (ver. 1.07; http://pngu.mgh.harvard.edu/~purcell/plink/index.shtml).31 Hardy-Weinberg 
equilibrium (HWE) testing was performed with exact test for controls and cases separately. Single-
marker association analysis was performed with chi-square test or exact test as appropriate. Haplotype 
analysis was also performed with logistic regression based on Wald test. Multiple comparisons were 
corrected by permutation tests. Permutation tests are based on re-sampling theory, and widely 
accepted as the gold standard for correction of multiple comparisons.32 In each permutation, the 
genotype data structure and the numbers of cases and controls were kept unchanged while the 
phenotype status of the subjects was randomly swapped (permutated). The statistic was calculated 
with each permutation and an empirical P value was generated based on 10,000 permutations. 
Permutation of the phenotype status among study subjects is valid under the assumption of null 
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hypothesis. In order to control experiment-wise (instead of marker-wise) type I error rates, each 
permutation involved all individual SNPs and all haplotypes for a given sample set genotyped 
individually (Sample Set 1, Sample Set 2 or Combined Sets, each separately), and this was repeated 
10,000 times. As such, the generated empirical P values controlled the experiment-wise (or more 
correctly, family-wise) type I error rates for a given sample set. 
 
RESULTS 
Analysis of ocular data 
This study had two sample sets collected from Han Chinese in Hong Kong. Sample Set 1 consisted of 
300 high myopes (cases) and 300 emmetropes (controls). The characteristics of these subjects have 
been reported previously.26 Cases (n=356) and controls (n=354) of Sample Set 2 were recruited using 
the same entry criteria as Sample Set 1, and their characteristics are summarized in Table 2 with the 
ocular data being shown for the right eye only, as has been done previously.26 Subjects of Sample Set 
2 were on average older than those of Sample Set 1: 34.0 years for cases and 33.1 years for controls of 
Set 2 (Table 2); and 27.7 years for cases and 24.9 years for controls of Set 1.26 However, cases and 
controls of Set 2 had very similar refractive error and axial length as their counterparts in Set 1. The 
mean SE for the right eye was -10.30 D for cases and 0.08 D for controls of Set 2, and -10.53 D for 
cases and 0.03 D for controls of Set 1. The mean axial length of the right eye was 27.64 mm for cases 
and 23.73 mm for controls of Set 2, and 27.76 mm for cases and 23.85 mm for controls of Set 1. 
 
Analysis of pooled DNA results 
Results of pooled DNA analysis are summarized in Table 3. The k correction factor ranged from 0.65 
to 1.45 with a mean of 1.07.  The estimated frequencies of the first eluted allele ranged from 0.0719 to 
0.8848 for case pools, and from 0.0939 to 0.8574 for control pools. The difference (case pools – 
control pools) in estimated allele frequencies ranged from -0.0597 to 0.0401. Of the 49 SNPs tested 
by the DNA pooling approach, only 3 SNPs showed significant difference in allele frequencies 
between case pools and control pools: rs2003241 (difference=0.0329, nested ANOVA P=0.0119), 
rs135029 (difference=-0.0597, P=0.0010) and rs137485 (difference=0.0351, P=0.0727). These three 
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SNPs were then genotyped for individual samples forming the DNA pools (Sample Set 1) for 
confirmation. The remaining 46 SNPs did not show significant differences in allele frequencies 
between case pools and control pools, and hence were not tested any further (Figure 1). 
 
Confirmation of pooled DNA results by individual genotyping 
The genotypes of the three follow-up SNPs were in HWE (P>0.05, exact test) for Sample Set 1. The 
only exception was rs135029 for the case group (P=0.0250). Deviation from HWE in cases can 
signify marker-disease association.33 Single-marker analysis showed that rs135029 of the TIMP3 gene 
was associated with high myopia (Pasym=0.0069, allelic test) while the other two SNPs (rs2003241 and 
rs137485) showed no significant differences between cases and controls (Sample Set 1, Table 4). In 
addition, haplotypes consisting of rs135029 and rs137485 (both in the TIMP3 gene) were also 
associated with high myopia (Pasym=0.0178, omnibus test; Sample Set 1, Table 5). These results 
remained significant after correction of multiple comparisons across single markers and haplotypes by 
permutation tests: Pemp=0.0162 (allelic test, Table 4) and Pemp=0.0496 (omnibus test, Table 5). 
Therefore, both rs135029 and rs137485 were further tested in a replication study using Sample Set 2. 
SNP rs2003241 was not tested any further (Figure 1). Note that the asymptotic P value is indicated as 
Paysm, and empirical P value as Pemp (also see footnotes to Tables 4 and 5). 
 
Replication study based on Sample Set 2 
The genotypes of both rs135029 and rs137485 were in HWE (P>0.05, exact test). Single-marker and 
haplotype analyses did not show any significant differences in allele or haplotype frequencies between 
cases and controls (Sample Set 2, Tables 4 and 5). We combined the sample sets (656 cases and 654 
controls in total) and re-analyzed the data with adjustment for age as a covariate because the mean age 
differed very significantly between Sample Sets 1 and 2 (difference=7.46 years, P <10-4 for t test). 
The results remained the same without significant differences in allele or haplotype frequencies 
between cases and controls (Combined, Tables 4 and 5). In other words, the initial positive results in 
Sample Set 1 could not be replicated independently by Sample Set 2. 
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DISCUSSION 
We adopted an efficient three-stage approach to investigating the relationship between high myopia 
and tag SNPs of three candidate genes (MMP2, TIMP2 and TIMP3). There are many experimental 
studies using animal myopia models which suggest the involvement of these genes in myopia 
development. In the initial stage, 49 tag SNPs were screened using a DNA pooling approach, and 3 
SNPs passed the lenient threshold of P ≤0.10 and were followed up. In the second stage, these three 
“putatively positive” SNPs were genotyped for individual samples forming the original DNA pools. 
In the third stage, two SNPs from stage 2 were genotyped for individual samples from a second 
sample set. However, the initial positive results could not be substantiated in the replication study. It 
is interesting to note that rs135029 of TIMP3 gave an OR of 1.26 for the combined sample set 
(Pasym=0.0344, Table 4), but did not survive after correction for multiple comparisons (Pemp=0.0693, 
Table 4). In view of this borderline significance, we explored the potential functional role of this SNP 
in the literature and using a web-based tool (FuncPred; http://manticore.niehs.nih.gov/snpfunc.htm) 
for prediction of SNP functions, but without success. In other words, MMP2, TIMP2 and TIMP3 were 
not associated with high myopia in the Han Chinese population under study, and are thus unlikely to 
play a major role in the genetic susceptibility to high myopia. 
 
 A recent Japanese study examined two functional promoter SNPs of the MMP2 gene in a 
case-control study involving 725 high myopes (SE ≤-6.0 D) and 546 population-based controls, and 
found no association of these two SNPs with high myopia.34 These two promoter SNPs were rs243865 
and rs2285053 (named as C -1306T and C -735T, respectively, in the report), and were not examined 
in the present study. The SNP rs243865 had an MAF of less than 0.10 in Han Chinese and hence did 
not satisfy the criteria of selecting tag SNPs in our study while the other SNP rs2285053 was not 
documented in the HapMap database. 
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 A US-based group recently examined 146 tag SNPs from 14 MMP and 4 TIMP genes for 55 
Amish families (358 individuals, mean SE = -1.61 D) and 63 Ashkenazi families (535 individuals, 
mean SE = -3.56 D).35 The tag SNPs were selected from the HapMap Caucasian (CEU) database with 
the criteria of MAF ≥0.15 and r 2 ≥0.7. In particular, 6 tag SNPs from MMP2, 11 from TIMP2 and 12 
from TIMP3 were included, which are expectedly less than those examined in our study (Table 1) 
because of their less restrictive criteria of SNP selection. Two SNPs were found significantly 
associated with ocular refraction by quantitative trait analysis using family-based association testing 
in the Amish families only, but not the Ashkenazi families. Both sets of families were sampled from 
largely endogamous, rapidly expanding, but isolated populations in the USA. The prevalence of 
refractive errors is high in Jewish populations,36 but relatively low in the Old Order Amish.37 The 
behavioral and environmental factors are more conducive to myopia development in the Jewish 
populations than in the Amish populations, and could probably explain the discrepancy in the genetic 
association results, as suggested by the authors.35 The authors also anticipated that the positive results 
could not be replicated in South Asian Chinese and Japanese populations with high prevalence of 
environmentally induced myopia.35 Indeed, our study could not replicate the findings. One of the 
positive SNPs in the Amish population was rs9928731 (P=0.00026) within the MMP2 gene.35 This 
SNP was also screened by the DNA pooling approach in the present study: the estimated frequency of 
the C allele was 0.5414 in case pools and 0.5015 in control pools, which were not statistically 
significant (difference=0.0399, nested ANOVA P value = 0.1435, Table 3). The frequency of the C 
allele in controls is similar to that in Han Chinese documented in HapMap database (0.5015 vs 
0.4560). It is worth noting that the phenotype definition was different for these two studies: 
quantitative measures of refractive errors in the American study, but dichotomous trait of high myopia 
(affected vs unaffected) in our study. 
 
 All three association studies (Japanese, American and our) focus on common polymorphisms 
in the genes under study and hence assumed the hypothesis of common disease common variants.38 
Strong linkage disequilibrium (LD) between common tag SNPs and common casual variants is critical 
to the success of this indirect LD mapping approach. Sequence variations must have similar allele 
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frequencies in order to be highly correlated and in strong LD. However, rare casual variants may also 
contribute to myopia development – the other side of the story being the hypothesis of common 
disease rare variants.38 This indirect approach is of low power in detecting association with rare 
variants because of the weak LD between common tag SNPs and rare casual variants. Therefore, 
direct mapping must be performed to detect association with rare causal variants, which must first be 
identified. Rare variants can be identified for direct association studies by sequencing of good 
candidate genes or even the whole genome for a very large number of samples.39 
 
 Our case subjects had extreme refractive errors (mean SE = -10.53 D for Set 1;26 and -10.30 D 
for Set 2, Table 2). This would enhance the homogeneity of the myopia phenotype, enrich the genetic 
components of the contributing factors, and hence increase the power of our study (though in a subtle 
manner). The three candidate genes were chosen for study because they have been shown to be 
involved in sclera remodeling in myopia development in many studies.11-22 Our negative finding 
might imply that these genes do not carry common sequence variants that are capable of influencing 
their function and/or regulation in the relevant ocular tissue. However, the contribution of behavioral 
and environmental effects on high myopia should not be overlooked. Our DNA pooling-based initial 
screen adopted a lenient threshold of P ≤0.10 in order avoid missing potential SNPs. For rs135029 of 
TIMP3, the power of the third stage study (Sample Set 2) is 73% under an allelic model and 78% 
under a genotypic model. The power is calculated based on the following assumptions with the online 
Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/): OR and allele frequencies 
obtained for rs135029 for Sample Set 1 (Table 4), a disease prevalence of 0.05 for high myopia in our 
local Chinese population,40 and a significance level set at α=0.025 because two SNPs were examined 
in the third stage. One disadvantage of DNA pooling strategy is that it makes haplotype analysis very 
difficult, if not impossible.24 Algorithms are available for estimating haplotype frequencies in small 
DNA pools constructed from a few (<10) individuals. In other words, our current pooling protocol 
might miss some potential SNPs for follow-up in the second stage analysis if high myopia is 
associated with certain haplotypes, but not individual SNPs. This is one of the reasons why a lenient 
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threshold of P ≤0.10 was used to selecting SNPs for follow-up study by individual genotyping in the 
second stage. 
 
 Association testing of DNA pools has been proven to be an effective initial screen of SNPs 
and candidate genes for subsequent detailed follow-up study.24,41 The major advantages are 
tremendous reduction in DNA usage and in the amount of genotyping work when compared to 
individual genotyping. For example, our study required for each SNP 36 PCRs and subsequent 
analyses for 6 case pools and 6 control pools (Fig. 2), plus three separate PCRs for heterozygotes to 
determine the k correction factor. The amount of genotyping work was only about one-fifteenth of 
that required for genotyping of 600 individual samples.  It has also been shown that use of small DNA 
pools of about 50 individuals is superior to use of fewer, larger DNA pools for candidate gene 
studies.25 In addition to the advantages mentioned above, use of small DNA pools allows the use of 
standard statistical method (nested ANOVA) for data analysis without the need of directly estimating 
the variance components of the error sources while it properly handles variations arising from 
sampling of subjects and technical errors, which are due to unequal amounts of DNA being mixed 
together, errors in PCR and primer extension, and in DHPLC analysis. 
 
 The present study used DHPLC analysis to estimate the relative allele frequencies of DNA 
pools. DHPLC analysis is in fact a rate-limiting step because samples have to be injected and 
analyzed sequentially. The throughput can be greatly increased if quantitative genotyping is 
conducted with a mass spectrometer,42 e.g. using the MassArray iPLEX method (Sequenom). 
However, the local service provider only entertained request of classical genotyping work based 
iPLEX method, but not quantitative genotyping. DNA pooling strategy may become less attractive as 
the unit cost of genotyping reduces tremendously with the availability of high-throughput genotyping 
platforms like whole-genome genotyping arrays. Nevertheless, the total cost of whole-genome 
genotyping for a large number of samples is still prohibitive for many research groups. In fact, 
genome-wide association studies can be within the reach of even small- to medium-sized research 
groups if DNA pooling strategy is applied.43 Interestingly, errors due to array variations are much 
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greater than those due to pool construction, and hence it is recommended to have multiple arrays per 
DNA pool for a few pools rather than multiple DNA pools with less arrays per pool.44 
 
 In conclusion, we used a DNA pooling strategy to screen 49 tag SNPs from three candidate 
genes (MMP2, TIMP2 and TIMP3). Three tag SNPs passed the threshold (P ≤0.10) and were tested by 
individual genotyping of samples forming the DNA pools. Two SNPs from the TIMP2 gene were 
found associated with high myopia by single-marker analysis or haplotype analysis. However, the 
initial positive results could not be replicated by an independent second sample set. Overall, these 
three candidate genes are unlikely to play a major role in the genetic susceptibility to high myopia in 
Chinese population. 
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FIGURE LEGEND 
Figure 1. A three-stage approach to testing genetic association based on an initial screen of DNA 
pools. 
 
Figure 2. Nested design of the DNA pooling study. There are two subject groups (case group, G2 ;and 
control group, G1), six DNA pools per group (P21 to P26 for case group, and P11 to P16 for control 
group), and three technical replicates (Rij1 to Rij3) for each DNA pool. Note that there is no link from 
any pools of the case group to any pools of the control group.  Therefore, the level of the case group is 
not cross-classified with the control group, but is nested with the respective group, i.e. the pools are 
nested within the group. Each DNA pool was constructed by mixing equal amounts of DNA from 50 
distinct individuals of the same subject group. 
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Table 1. Summary of tag SNPs in the MMP2, TIMP2 and TIMP3 genes 
Gene GeneID 
Chromosomal 
location 
Region 
captioned* 
No. of tag 
SNPs 
No. of SNPs captured 
at mean r2 =? 
MMP2 4313 16q13-q21 33.5 kb 17 43 (r2 = 0.994) 
TIMP2 7077 17q25 78.4 kb 17 52 (r2 = 0.973) 
TIMP3 7078 22q12.3 68.2 kb 15 37 (r2 = 0.960) 
* The region captured includes the gene and its flanking region (3 kb upstream and 3 kb downstream). 
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Table 2. Characteristics of study subjects of Sample Set 2 (for right eyes only) 
Characteristic Cases (n=356) Controls (n=354) 
Age, mean (SD), y 34.0 (9.1) 33.1 (9.5) 
Females, no. (%) 236 (66.3) 209 (59.0) 
Spherical equivalent, mean (SD), D -10.30 (2.46) 0.08 (0.53) 
Axial length, mean (SD), mm 27.64 (1.18) 23.73 (0.82) 
Corneal power, mean (SD), D 44.38 (3.71) 43.97 (1.51) 
Anterior chamber depth, mean (SD), mm 3.34 (0.38) 3.20 (0.41) 
Lens thickness, mean (SD), mm 4.30 (0.50) 4.33 (0.57) 
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Table 3. Pooled DNA analysis of tag SNPs in the MMP2, TIMP2 and TIMP3 genes 
 Alleles† k correction factor Estimated frequencies of 1st allele nANOVA 
SNP* (1st/2nd) peak height ratio (1st/2nd) Case pools Control pools Diff (Case - Control) P value 
MMP2       
rs11643630 T / G 1.01  0.4573 0.4534  0.0039 0.9029 
rs1477017 G / A 1.12  0.3064 0.2958  0.0106 0.5585 
rs865094 G / A 0.96  0.3268 0.3335 -0.0067 0.7647 
rs11076101 C / T 1.01  0.7637 0.7855 -0.0218 0.3412 
rs17301608 C / T 1.06  0.6557 0.6801 -0.0244 0.2008 
rs11646643 G / A 1.02  0.1817 0.1702  0.0115 0.6305 
rs2241146 G / A 1.01  0.7749 0.7736  0.0013 0.9427 
rs9928731 C / T 1.11  0.5414 0.5015  0.0399 0.1435 
rs12599775 C / G 1.25  0.1659 0.1819 -0.0160 0.5207 
rs243847 C / T 1.09  0.4084 0.4196 -0.0112 0.7028 
rs243845 G / A 1.05  0.7187 0.6907  0.0280 0.3367 
rs243843 G / A 1.04  0.4285 0.4466 -0.0181 0.4689 
rs183112 G / A 1.32  0.6643 0.6718 -0.0075 0.7514 
rs1992116 G / A 1.02  0.6671 0.6945 -0.0274 0.2274 
rs11639960 G / A 1.07  0.2801 0.2763  0.0038 0.8187 
rs243835 C / T 1.05  0.4218 0.3817  0.0401 0.2328 
rs1861320 G / T 1.23  0.7969 0.8195 -0.0226 0.5003 
TIMP2       
rs4789932 C / T 1.07  0.3519 0.3551 -0.0032 0.9259 
rs8080623 C / T 1.15  0.2968 0.2975 -0.0007 0.9770 
rs8179091 C / T 0.96  0.4432 0.4465 -0.0033 0.9115 
rs7212662 C / A 1.17  0.2912 0.2972 -0.0060 0.8225 
rs8066695 G / A 1.03  0.374 0.3907 -0.0167 0.5461 
rs12600817 C / T 0.65  0.5475 0.5774 -0.0299 0.4249 
rs4789860 G / A 1.09  0.2553 0.2584 -0.0031 0.9410 
rs2889529 C / T 1.23  0.3255 0.3202  0.0053 0.8840 
rs2376999 C / T 1.01  0.3446 0.3235  0.0211 0.3401 
rs2003241 G / A 0.97  0.2458 0.2129  0.0329 0.0119 
rs7502935 C / T 1.45  0.6973 0.6914  0.0059 0.8301 
rs6501258 A / T 1.20  0.5172 0.5019  0.0153 0.5409 
rs6501256 G / A 1.01  0.2361 0.2166  0.0195 0.4293 
rs11868442 G / A 1.36  0.6678 0.6783 -0.0105 0.7285 
rs2277698 G / A 1.21  0.7445 0.736  0.0085 0.7413 
rs9905930 G / T 1.01  0.7625 0.766 -0.0035 0.8442 
rs16971783 T / A 1.00  0.1017 0.1042 -0.0025 0.8263 
TIMP3       
rs1962223 G / C 1.08  0.6029 0.6245 -0.0216 0.4599 
rs9619311 G / A 0.99  0.129 0.152 -0.0230 0.2400 
rs242089 C / T 1.04  0.5167 0.5126  0.0041 0.8976 
rs80272 G / A 1.01  0.105 0.1306 -0.0256 0.2691 
rs8140818 G / A 1.01  0.0719 0.0939 -0.0220 0.2107 
rs242076 C / T 0.92  0.5287 0.5623 -0.0336 0.4067 
rs715572 C / T 1.04  0.64 0.6452 -0.0052 0.8863 
rs242072 G / A 1.01  0.4711 0.4663  0.0048 0.8683 
rs135029 C / T 1.03  0.7898 0.8495 -0.0597 0.0010 
rs241890 C / A 1.18  0.5981 0.5901  0.0080 0.7674 
rs1427385 G / A 1.03  0.5344 0.5391 -0.0047 0.8962 
rs9609643 C / T 1.12  0.8848 0.8574  0.0274 0.1511 
rs9862 G / A 0.95  0.5242 0.5439 -0.0197 0.5089 
rs11547635 A / G 0.98  0.3424 0.327  0.0154 0.5151 
rs137485 A / T 0.85  0.2440 0.2089  0.0351 0.0727 
* SNPs are arranged down the column in the order of 5’>3’ along the respective gene. 
† The 1st allele has a shorter elution time while the 2nd allele has a longer elution time. The alleles are named with reference to the 
sense strand of the respective gene. 
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Table 4. Allelic association tests of TIMP2 and TIMP3 SNPs genotyped individually 
 Alleles* Genotype counts (11/12/22)* Minor allele freq  Allelic test‡ 
Gene, SNP 1 2 Cases Controls Cases Controls OR (95%CI) † Pasym Pemp 
Sample Set 1 
TIMP2, rs2003241 A G 189/93/10 201/84/12 0.1935 0.1818 1.08 (0.81 - 1.45) 0.6078 0.9374 
TIMP3, rs135029 C T 188/106/5 223/69/6 0.1940 0.1359 1.53 (1.12 - 2.09) 0.0069 0.0162 
TIMP3, rs137485 T A 209/84/4 228/62/7 0.1549 0.1279 1.25 (0.90 - 1.73) 0.1828 0.4466 
Sample Set 2 
TIMP3, rs135029 C T 260/87/8 261/83/9 0.1451 0.1431 1.02 (0.76 - 1.37) 0.9142 0.9966 
TIMP3, rs137485 T A 259/87/6 271/66/9 0.1406 0.1214 1.18 (0.87 - 1.62) 0.2870 0.5231 
Combined (Sets 1 & 2)§ 
TIMP3, rs135029 C T 448/193/13 484/152/15 0.1674 0.1398 1.26 0.0344 0.0693 
TIMP3, rs137485 T A 468/171/10 499/128/16 0.1471 0.1244 1.24 0.0917 0.1268 
* The major allele is designated as “1” and minor allele as “2”; and the genotype counts are indicated as the counts of the 
genotypes 11, 12 and 22, respectively. Sample Set 1 has 300 cases and 300 controls while Sample Set 2 has 356 cases and 
354 controls. Note that the total genotype counts may not add up to these expected numbers because a few samples failed 
to be genotyped in a random fashion. 
† The odds ratio (OR) is calculated for the minor allele (allele 2) with the major allele (allele 1) as the reference. The 95% 
confidence intervals (CI) are indicated within brackets. 
Since rs135029 is of interest, its genotypic odds ratios and their 95% CI (in brackets) are given here with CC as the 
reference genotype: 1.82 (1.27 – 2.61; Set 1), 1.06 (0.75 – 1.50; Set 2), 1.37 (1.08 – 1.77; Combined Set, not adjusted for 
age here) for genotype CT, and 0.99 (0.30 – 3.29; Set 1), 0.90 (0.34 – 2.37; Set 2) and 0.94 (0.44 – 2.00; Combined Set, 
not adjusted for age here) for genotype TT. This simply serves to avoid cluttering in the table above. 
‡ Allele frequencies are compared by chi-square test to give the asymptotic P value (Pasym). Multiple comparisons are 
corrected by 10,000 permutations across single marker allelic tests (this table) and omnibus tests of haplotypes (Table 4) 
for a given sample set (Set 1, Set 2 or Combined, each separately). The empirical P value is indicated as Pemp. 
§ Single-marker (this table) and haplotype (Table 5) analyses are performed for the combined sample set (Sets 1 and 2) with 
adjustment for age as a covariate to account for the effect of age. This has to be done using logistic regression, the relevant 
PLINK command of which does not give the 95% CI for the odds ratio (OR). 
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Table 5. Haplotype analysis of 2 TIMP3 SNPs (rs135029-rs137485)* 
 Haplotype freq    
Haplotype Cases Controls OR Pasym Pemp 
Sample Set 1 
Omnibus test - - - 0.0178 0.0496 
TA 0.1431 0.1102 1.38 0.0785  
CA 0.0118 0.0186 0.62 0.3350  
TT 0.0522 0.0254 2.11 0.0201  
CT 0.7929 0.8458 0.69 0.0172  
      
Sample Set 2 
Omnibus test - - - 0.2380 0.4293 
TA 0.1028 0.1033 1.00 0.9780  
CA 0.0368 0.0185 2.00 0.0463  
TT 0.0425 0.0387 1.10 0.7260  
CT 0.8179 0.8395 0.86 0.2890  
      
Combined (Sets 1 & 2) † 
Omnibus test - - - 0.0690 0.1381 
TA 0.1219 0.1070 1.20 0.1560  
CA 0.0247 0.0180 1.35 0.2680  
TT 0.0463 0.0320 1.43 0.0829  
CT 0.8071 0.8430 0.77 0.0118  
* Asymptotic P values (Pasym) are obtained from Wald test based on logistic regression. Multiple comparisons are corrected 
by 10,000 permutations across single marker allelic tests (Table 3) and omnibus tests of haplotypes (this table) for a given 
sample set (Set 1, Set 2 or Combined, each separately). The empirical P value is indicated as Pemp. Note that PLINK does 
not generate confidence intervals for odds ratios (OR) in haplotype analysis. 
† Single-marker (Table 4) and haplotype (this table) analyses are performed for the combined sample set (Sets 1 and 2) with 
adjustment for age as a covariate to account for the effect of age. This has to be done using logistic regression, the relevant 
PLINK command of which does not give the 95% CI for the odds ratio (OR). 
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Supplementary Table S1. MMP2, TIMP2 and TIMP3 SNPs: primers for PCR and primer extension reaction and buffer B concentration ranges for DHPLC 
SNP* Forward PCR primer (5'>3') Reverse PCR primer (5'>3") PE primer (5’>3’) ddGTP ddCTP ddTTP ddATP Buffer B (%) 
MMP2         
rs11643630 GGTAAATTATTCATGCTTCTGCCTTTT TGGCACAAGATACAGGTCATAAA ACCAAAACCAAGATGATGATGAG  √  √ 23-29% 
rs1477017 TCCCTCGCAAGCCCAAGT GCACTGAAAAGTAACCCAATGTC TGTGTATTGAAACTCCCTAAGATG  √ √  26-32% 
rs865094 CATCTTAGGGAGTTTCAATACACA GCTACCAATCATCACGTTCCTT ACAGACTTGAGTTTCATACTTGCT √   √ 27-33% 
rs11076101 GGCTTAGATAGGACAGTAGATG TGCCCAGTGTGACCAGGAAA CATCTGCCCCCATGTCAAC √   √ 22-28% 
rs17301608 GTTGGATGATGCTGGTAGACA TCCTGTCAATACTGCCCTCTTA TGTAGACACTAGAGGAAGGGT  √ √  23-29% 
rs11646643 GTAAAGAGCAGGGGAAACAATG TACCACATACCCACATTACCAC GGATGGAGGATGGCATAGAC √   √ 22-28% 
rs2241146 CAGAATGGACAGTGCCCTTG AGAGAGGGAAGGATGTGAATGA GTGTCAATCATTTTGTTGTTGGGTG √   √ 27-33% 
rs9928731 CAGAACAGACATTGGGCATC CTGTTGGAGGAAGGGAAGAA GTCTGTATCTCCACCTTTTAGTC  √ √  26-32% 
rs12599775 CGACCACAGCCAACTACGA GGAGGTGAGTAGCAGCATCT GACCCTGGACATTGCCCTT √ √   23-29% 
rs243847 AGACACCCACCTACCCAGA GCAGTGGGAATGTCTCTTAGG GATGCTGCTACTCACCTCC  √ √  22-28% 
rs243845 GTTGGTTCTTACAGTGAGGCTA GCAGACCTTGGGCTTTTTCC GAGCCAGGCCAAAATAGTGAAA √   √ 22-28% 
rs243843 GCTTGCTTCTTGTCCTCCTT AGCACACCTGAACCCAAACT GTCATTCTGGGAAGCATTTGG  √ √  24-30% 
rs183112 AGCCTCCACTCACATCTTGT TCACTCACCACCCATACACA GTTCCCAATTCTTCCCTCCATTT  √ √  29-35% 
rs1992116 TGTGTATGGGTGGTGAGTGAC GGATGGATGATAGAAGAATGGAAG GCCCTAGTTCCCTGGAGAAT √   √ 23-29% 
rs11639960 GTCTTCACTCTTCACTACTATTC CTGATTTGGATGCTGGCTTC TAAGTCTTCTTCATATTTTGTCCAC  √ √  27-33% 
rs243835 CACACTGTTTGGCATGTAGTAAG CATTTTCTTCTTCACCTCATTGTATC GCCATCAGCTGGGTGCTC  √ √  20-26% 
rs1861320 CCCACTCCTAATCTCCTACATA CAGAAAAAAGAGATAGAAACAATGACA CACCTGTAGAGTTCACTCCTTA  √  √ 25-31% 
         
TIMP2         
rs4789932 CACCTCACTCAGAACAAAATGC TTCTGTTCCCTCTACCATTATCTC ACGGTGTCCAGGCTACAG  √ √  21-27% 
rs8080623 CTGGAGTGCTGACCTGAGT ATGTGGGAGCCGAAGGACT ACCACCCTACACATGTTCATC  √ √  25-31% 
rs8179091† GAGTCGAGCTGAAGGGGAAA CGCTCGGAGGATTTTCTGCT CGGGTGGGTCGCCTGGTG  √ √  18-24% 
rs7212662 CTTGCTCAGACTTCGGCTTT GCAGCCAAGAGTAAAAGGAG GCCCACAGGTGATTTAACC  √  √ 22-28% 
rs8066695 ATCCGCTCAGACACTACCAC GGAAGACAACCACAGAACCT AACCAGCTCTGGGGAAAGG √   √ 20-26% 
rs12600817 TGGGTCCGTATTAGGGTTTC TCACAGACAGCAGATTCCAG TTCCCACATAAATCCCATCTTAC √   √ 25-31% 
rs4789860 TAATGGACGCTGTCGAGGTAT CATATTGGTCAGACTGGTTACAAA TGAATCTGTGTGTATCCATATCC  √ √  26-33% 
rs2889529 CCTCCTTTGGCTTTTCTTCCTA TACGAAGTGCCTGTGCTCTA ACACCTCTCCCTCGTTCAGATT  √ √  25-31% 
rs2376999 CTGGGTAGTAAGAGGTGTTCAT CACAATGGATCATAGACCTTCAT CACCAAAAGCACAACCAATAAAC √   √ 24-30% 
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SNP* Forward PCR primer (5'>3') Reverse PCR primer (5'>3") PE primer (5’>3’) ddGTP ddCTP ddTTP ddATP Buffer B (%) 
rs2003241 CTCAGAAGCAGCCACAGATG ATTCTGGGTCTTGGGTCTGG AGACTCTACAAAAATAGGTGGTG √   √ 25-31% 
rs7502935 GCCCCATCCTGCTAAAAGAA TCTGAAAAGGGAGGTGAAGC TCTAAGCTGTCTTTACTGTGATC  √ √  26-35% 
rs6501258 GTGTGATTTGAGGGTGTGGA TCATTTGGCTCTGGGTGGAA AGGTGGACTCAGCTTTGTTC   √ √ 24-30% 
rs6501256 TCTCTTGATTCCCATTTTCCTTCTTT AAGAGGAGGCTGGTCAAATCA TGCCCACCCCCAATTTAAAG √   √ 24-30% 
rs11868442 AGTGGTAGAATAGTGGGAGCAT TCTTCTTTCTTCTTCTGTTGGAG ACAGACGGCTTTGCCCTGA  √ √  22-28% 
rs2277698 CCTCCTCCTTGTCTTTCCAG TACCCTGCCTCACTGTTCCT TTCTTTCCTCCAACGTCCAG  √ √  25-31% 
rs9905930 GCTCTGACACCTGACTCGTTA AGTGCTGTGCTGCGTGTATG GGAGTAGGAGACCAGAAATGAT √  √  23-29% 
rs16971783 GGAGAAAAGGACCCGAAGATAAA TGGAAATGTGGATGGCTTGC AACAGGAAGTGCGAGCATAAG   √ √ 22-28% 
         
TIMP3         
rs1962223 AAGTGGAAACAAAAAATCAAAAGACCT TGCGAAACTGATGGATGGTCT TATCTTTCATCCAATAAACACAGAAGT √ √   28-34% 
rs9619311 GCTGAGAAGTGGACAAAGACA CTTGTGCTTGCTTTTCCTACC CCTGCCCATGGCTGACAG √   √ 20-26% 
rs135025 AGATAGATGATAAATGATAAATAGAAATGGATA AACAAAAACAACAACACGATTCTCC GCCACCCAGGAGTAGACTA  √ √  23-29% 
rs242089 CAATCACAATGGCAGGCAAG TAGGTGGGAGAATCGCTTGA TGCTGCATGGTGACCTGTTT √   √ 24-30% 
rs80272 ATAGGGAGGAGGCTGGTAGT TGACCTGCCTGATGCTACCT CAGCACTGAATCTGGGAAC √   √ 22-28% 
rs8140818 ACTTGGGAGGCTGAGGGAAA CCAGGGCTCTTCTTGCTATT GAGACTCTGTCTCAGAAAAAGAG √   √ 24-30% 
rs242076 AGAAAGCAGGAGGATGGTCA CTAAAAGATGGGCTAATGACAACA AAAATCCACGGAAAGCATTTAGC √   √ 24-30% 
rs715572 CTGAAATGCTACCTCCTCCA TCCCACAGCCTCATTCATTCA CTTTCCTCTCTTTCTTCCAGCA  √ √  25-31% 
rs242072 CAGCCACTCTTGATTTCTTCCT GCCTCATTGGACCCTTAGAA GATTCCTGGATTCAGGGCC √   √ 21-27% 
rs135029 AGCAAGGCAAACAAGGCACA GAAGGGTCTGGATTTGGTTGA GTTTCCAGAAAAGCTTACTGGTG  √ √  25-31% 
rs241890 TGGAGAAGCACAGATGAAGTAG AATAGGTGGATCTGGGGTTG CCCAAGAATTGCCTACTAAGAC  √  √ 23-29% 
rs1427385 AGGGCAGTATTAGCATCCACAT CGTAGAAAGAGAAGCACAACCT GGGAATTGGAATCAGGATTGAAC √   √ 24-30% 
rs9609643 TTATCCCCTCAGTTCTCAGC GAAGAGACACCAATGAAGAGATG GTTTATAATAGGAAAATGCCTCTACTTTA  √ √  29-35% 
rs9862 AGCAGGTACTGGTACTTGTTGA GATGGGCACTTAGGTTGATTTC CCCATGTGCAGTACATCCA  √ √  21-27% 
rs11547635 AACATTAGAGACTCCTTACAATTTACT CAGACCCCTCTTCCATATTC TTAAGGCCACAGAGACTCTC dGTP‡   √ 25-31% 
rs137485 GAGCCCACTTGAAACCACTT TTGCAGCCCTAGAAACATCAG GGTCTGAGCAGATATAGTAAGGA   √ dATP‡ 26-32% 
* SNPs are arranged down the column in the order of 5’>3’ along the respective gene. 
† Dimethylsulfoxide (5%) was added as additive in the PCR. 
‡ dNTP was used for the primer extension reaction for an optimal discrimination of the extended products. 
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Supplementary Table S2. Primers and probes for genotyping individual samples 
Gene, SNP  Primer sequences (5’>3’)* 
MassArray iPLEX (Sequenom) for Sample Set 1 
TIMP2, rs2003241 F: ACGTTGGATGAACTATGGCACAAAGGGCAG 
 R: ACGTTGGATGAAATGAAAGGGCGTGGCCAG 
 PE primer: taagGAGACTCTACAAAAATAGGTGGTG 
  
TIMP3, rs135029 F: ACGTTGGATGCAATGGCAATTGGGATTGAG 
 R: ACGTTGGATGGATGAACAGCACATGTGCAA 
 PE primer: tgaaaATGTGCAATTTCTGGAGAC 
  
TIMP3, rs137485  F: ACGTTGGATGGAAAGGCATTCTTCCTTCCC 
 R: ACGTTGGATGGCAGGTCTGAGCAGATATAG 
 PE primer:  CTGAGCAGATATAGTAAGGA 
  
Unlabeled probe melting analysis for Sample Set 2 
TIMP3, rs135029 F: GAA GAA GGG TCT GGA TTT GGT T  
 R: AGT ATG GAT CAC AGT GGC ACA A  
 Probe: AGC TTA CTG GTG CGT CTC AAG AAA TTG C 
  
TIMP3, rs137485 F: CTG ACT TAC AGC CCT AGA AAC A  
 R: GAC TCA AGA GCC CTC ATG C 
  Probe: TCT GAG CAG ATA TAG TAA GGA TTG TTG CC 
* F = forward primer; R = reverse primer; and PE = primer extension 
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Supplementary materials for statistical analysis (nested ANOVA) 
 
Here, we briefly explain the principle of nested analysis of variance (ANOVA) used to analyze the 
estimated allele frequencies of DNA pools. Nested ANOVA design is an extension of one-way 
ANOVA design. All assumptions (e.g. normality of residuals, constant variance, etc) of ANOVA hold 
true for nested ANOVA. Our nested design had one measurement variable (the estimated allele 
frequency, Rijk) and two nominal variables (DNA pools and subject groups) with the DNA pools (Pij) 
nested within each of the subject groups (Gi) (Fig. 2 in main text). There were two subject groups 
(case group and control group, i=1,2), six DNA pools (j=1,2,3,4,5,6) within each subject group, and 
three replicates (k=1,2,3) per DNA pool. Nested ANOVA assessed the difference between the case 
group (high myopia) and the control group (emmetropia) to test for allele frequency difference 
between these two subject groups – the main objective of the pooling experiments. It could also assess 
the variability of the DNA pools within subject groups, which, however, was not the main objective of 
the pooling-based screen and was expected to be large because each DNA pool was prepared from the 
DNA of 50 distinct subjects within the same subject group. 
 
 
